| |
| |
|
| Insider
Information: |
Patel Sanj K |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
63,012 |
|
|
Indirect Shares
|
109,795 |
|
|
| Direct
Value |
$1,214,241 |
|
|
|
Indirect Value
|
$2,115,750 |
|
|
| Total
Shares |
172,807 |
|
|
| Total
Value |
$3,329,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-08-31 |
4 |
OE |
$0.95 |
$14,428 |
D/D |
15,187 |
16,218 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-03 |
4 |
OE |
$0.95 |
$15,641 |
D/D |
16,464 |
17,495 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-10-09 |
4 |
AS |
$21.00 |
$18,312 |
D/D |
(872) |
0 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2022-03-16 |
4 |
D |
$10.13 |
$19,470 |
D/D |
(1,922) |
4,647 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-08 |
4 |
OE |
$0.95 |
$20,610 |
D/D |
21,695 |
22,726 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-04-04 |
4 |
OE |
$0.95 |
$20,834 |
D/D |
21,931 |
22,962 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-04 |
4 |
OE |
$0.95 |
$21,850 |
D/D |
23,000 |
24,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2022-09-02 |
4 |
D |
$11.44 |
$22,068 |
D/D |
(1,929) |
22,396 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-03-16 |
4 |
D |
$11.46 |
$22,106 |
D/D |
(1,929) |
27,036 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-20 |
4 |
OE |
$0.95 |
$23,378 |
D/D |
24,608 |
25,639 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-10 |
4 |
AS |
$23.07 |
$26,231 |
I/I |
(1,137) |
83,336 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-11 |
4 |
OE |
$0.95 |
$28,166 |
D/D |
29,648 |
30,679 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-03 |
4 |
OE |
$0.95 |
$28,500 |
D/D |
30,000 |
31,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-17 |
4 |
OE |
$0.95 |
$30,703 |
D/D |
32,319 |
33,350 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-04-10 |
4 |
D |
$10.71 |
$31,412 |
D/D |
(2,933) |
42,574 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
OE |
$1.59 |
$32,438 |
D/D |
20,401 |
20,401 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-10 |
4 |
AS |
$23.06 |
$36,896 |
D/D |
(1,600) |
0 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-01 |
4 |
D |
$19.70 |
$37,489 |
D/D |
(1,903) |
57,095 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-09-02 |
4 |
D |
$17.76 |
$38,841 |
D/D |
(2,187) |
52,516 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-03-20 |
4 |
D |
$11.12 |
$39,176 |
D/D |
(3,523) |
35,515 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-02-21 |
4 |
OE |
$0.95 |
$43,122 |
D/D |
45,392 |
46,423 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-25 |
4 |
OE |
$0.95 |
$45,319 |
D/D |
31,915 |
32,946 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-03-23 |
4 |
OE |
$0.95 |
$47,500 |
D/D |
50,000 |
51,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-06-12 |
4 |
OE |
$0.95 |
$49,383 |
D/D |
40,352 |
41,383 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-09-04 |
4 |
OE |
$0.95 |
$52,072 |
D/D |
54,813 |
55,844 |
0 |
- |
|
93 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
